Fifty-six of 135 IgAN patients (41%) but only eight nineof 79 (11%) CKD controls had a serum Gd-IgA1 level higher than the 90th percentile for healthy controls (P = 5.5×10-7 for differences in distribution in IgAN patients vs. CKD controls). Here, IGHA1 is linked to chronic kidney disease.